Target Validation Information | |||||
---|---|---|---|---|---|
TTD ID | T25464 | ||||
Target Name | Calcineurin (PPP3CA) | ||||
Type of Target |
Successful |
||||
Drug Potency against Target | Ciclosporin | Drug Info | IC50 = 10 ng/mL | [2] | |
Pimecrolimus | Drug Info | IC50 = 0.6 ~ 1.0 nM | [4] | ||
Tacrolimus | Drug Info | IC50 = 11.1 nM | [1] | ||
Ciclosporin | Drug Info | IC50 = 100 nM | [3] | ||
References | |||||
REF 1 | 32-Indolyl ether derivatives of ascomycin: three-dimensional structures of complexes with FK506-binding protein. J Med Chem. 1999 Jul 29;42(15):2798-804. | ||||
REF 2 | Tissue distribution of calcineurin and its sensitivity to inhibition by cyclosporine. Am J Transplant. 2001 Nov;1(4):325-33. | ||||
REF 3 | Substitution in position 3 of cyclosporin A abolishes the cyclophilin-mediated gain-of-function mechanism but not immunosuppression. J Biol Chem. 2004 Jan 23;279(4):2470-9. | ||||
REF 4 | Pimecrolimus: absorption, distribution, metabolism, and excretion in healthy volunteers after a single oral dose and supplementary investigations i... Drug Metab Dispos. 2006 May;34(5):765-74. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.